1. Home
  2. BWMX vs TRDA Comparison

BWMX vs TRDA Comparison

Compare BWMX & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWMX
  • TRDA
  • Stock Information
  • Founded
  • BWMX 1995
  • TRDA 2016
  • Country
  • BWMX Mexico
  • TRDA United States
  • Employees
  • BWMX N/A
  • TRDA N/A
  • Industry
  • BWMX Catalog/Specialty Distribution
  • TRDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BWMX Consumer Discretionary
  • TRDA Health Care
  • Exchange
  • BWMX Nasdaq
  • TRDA Nasdaq
  • Market Cap
  • BWMX 495.6M
  • TRDA 264.4M
  • IPO Year
  • BWMX N/A
  • TRDA 2021
  • Fundamental
  • Price
  • BWMX $14.27
  • TRDA $6.95
  • Analyst Decision
  • BWMX Strong Buy
  • TRDA Strong Buy
  • Analyst Count
  • BWMX 2
  • TRDA 2
  • Target Price
  • BWMX $22.50
  • TRDA $24.50
  • AVG Volume (30 Days)
  • BWMX 48.2K
  • TRDA 192.6K
  • Earning Date
  • BWMX 10-23-2025
  • TRDA 11-06-2025
  • Dividend Yield
  • BWMX 10.04%
  • TRDA N/A
  • EPS Growth
  • BWMX 15.49
  • TRDA N/A
  • EPS
  • BWMX 1.49
  • TRDA N/A
  • Revenue
  • BWMX $775,128,445.00
  • TRDA $61,520,000.00
  • Revenue This Year
  • BWMX $3.50
  • TRDA N/A
  • Revenue Next Year
  • BWMX $5.30
  • TRDA N/A
  • P/E Ratio
  • BWMX $9.35
  • TRDA N/A
  • Revenue Growth
  • BWMX 3.60
  • TRDA N/A
  • 52 Week Low
  • BWMX $7.00
  • TRDA $4.93
  • 52 Week High
  • BWMX $15.00
  • TRDA $21.79
  • Technical
  • Relative Strength Index (RSI)
  • BWMX 58.94
  • TRDA 58.77
  • Support Level
  • BWMX $13.61
  • TRDA $6.09
  • Resistance Level
  • BWMX $14.43
  • TRDA $7.10
  • Average True Range (ATR)
  • BWMX 0.64
  • TRDA 0.48
  • MACD
  • BWMX 0.05
  • TRDA -0.01
  • Stochastic Oscillator
  • BWMX 70.60
  • TRDA 59.52

About BWMX Betterware de Mexico S.A.P.I. de C.V.

Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: